[Mode of anti-inflammatory action of sodium salicylate and its relationship to the pituitary-adrenal axis].
D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001205:Ascorbic Acid; D001206:Ascorbic Acid Deficiency / Q000139:chemically induced; D001368:Axis, Cervical Vertebra / Q000187:drug effects*; D003983:Dibenzylchlorethamine; D004487:Edema / Q000188:drug therapy; D004837:Epinephrine; D006584:Hexamethonium Compounds; D007490:Iproniazid; D008297:Male; D008797:Metyrapone; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D012980:Sodium Salicylate / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D006584:Hexamethonium Compounds; D003983:Dibenzylchlorethamine; D007490:Iproniazid; D001205:Ascorbic Acid; D012980:Sodium Salicylate; D004837:Epinephrine; D008797:Metyrapone